NFO period: 20^th November – 04^th December, 2023

Highlights of the NFO:

• Scheme type – An open ended equity scheme investing in Pharma, Healthcare & allied sectors


• Investment objective – The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.


• Product suitability – The product is suitable for investors who are seeking long term capital growth by investing in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors.


• Minimum Application Amount – First investment Rs. 5,000/- and in multiple of Rs. 1/- thereafter


• Plan/ Options available – Regular Plan and Direct Plan having Growth Option and Income Distribution cum capital withdrawal (IDCW) Option (Payout and Reinvestment).


• Fund Managers – Ms. Shibani Sircar Kurian, Mr. Dhananjay Tikariha, Mr. Abhishek Bisen and Mr. Arjun Khanna


• Benchmark – Nifty Healthcare Index (Total Return Index)